HemoTypeSC Has a CE Mark and is Registered in Ghana, Nigeria, and Kenya

ASH Clinical News Interview - HemoTypeSC Late-Breaking Abstract

Erik Serrao, HemoTypeSC Product Manager at Silver Lake Research Corporation, discusses with ASH Clinical News the data from a recently-completed field validation trial in southeastern Uganda.  In this collaboration with the Sickle Cell Association of Uganda, led by Ruth Nankanja, HemoTypeSC correctly identified the hemoglobin type of 1,000 out of 1,000 children screened.